DENTSPLY SIRONA Inc.
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies primarily for professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression and restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials; and laboratory-based CAD/CAM milling systems, amalgamators, mixing machines, and porcelain furnaces. In addition, it provides dental technology products, including dental implants and related scanning equipment, and treatment software; orthodontic clear aligners and appliances for dental practitioners and specialist; and dental equipment, such as treatment centers, imaging equipment, dental handpieces, and computer aided design and machining systems for dental practitioners. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers; dental hygienists, assistants, laboratories, and schools; and urology products directly to patients, as well as through distributors to urologists, continence care nurses, general practitioners, and direct-to-patients. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
IPO Year: 1987
Exchange: NASDAQ
Website: dentsplysirona.com
Peers
Recent Analyst Ratings for DENTSPLY SIRONA Inc.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/13/2025 | Buy → Hold | Needham | |
| 2/14/2025 | $20.00 | Equal Weight | Wells Fargo |
| 1/23/2025 | $30.00 → $20.00 | Buy → Hold | Jefferies |
| 1/7/2025 | $20.00 | Outperform → In-line | Evercore ISI |
| 12/4/2024 | $21.00 | Neutral | Mizuho |
| 11/7/2024 | Outperform → Market Perform | Leerink Partners | |
| 10/25/2024 | $34.00 → $29.00 | Buy | Needham |
| 8/20/2024 | $34.00 | Buy | Needham |
| 2/26/2024 | $42.00 | Outperform | Leerink Partners |
| 11/16/2023 | $35.00 | Buy | Needham |
DENTSPLY SIRONA Inc. Press Releases
Fastest customizable press release news feed in the world
Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader
CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion. David Ferguson joins Dentsply Sirona with 25 years of experience in MedTech and healthcare with a proven track record of delivering results, competing in a global marketplace and leading global product strategy. Mr. Ferguson has se
Dentsply Sirona to Participate in the Leerink Partners Global Healthcare Conference 2025
CHARLOTTE, N.C., March 04, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will participate in the Leerink Partners Global Healthcare Conference. Management is scheduled to present on Tuesday, March 11, 2025, at 3:00 pm ET. Investors and other interested parties will be able to access a live audio webcast and an audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook
FY24 net sales of $3,793 million decreased (4.3%), organic sales decreased (3.5%) including a (1.2%) Byte sales impactFY24 GAAP net loss of ($910) million or ($4.48) per share, adjusted EPS of $1.67Q4 net sales of $905 million decreased (10.6%), organic sales decreased (10.7%) including a (6.0%) Byte sales impactQ4 GAAP net loss of ($430) million or ($2.16) per share, adjusted EPS of $0.26FY25 outlook: net sales in the range of $3.50 billion to $3.60 billion with organic sales down (4.0%) to (2.0%); adjusted EPS of $1.80 to $2.00(1) CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial resul
Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business ("Wellspect"). Wellspect is a leading provider of bladder and bowel management care products with an over 40-year history. Through its comprehensive portfolio of products and accessories from trusted brands like LoFric® and Navina™, Wellspect has delivered improved organic sales growth in recent years, including mid-to-high single digit growth for 2023 and through the first three quarters of 2024. The business is well-positioned in the larg
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members
CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the "Board"), effective February 5, 2025. Mr. Barber brings over 40 years of experience in product management and innovation, including executive leadership roles at GE, where he was responsible for the transformation of the company's digital X-Ray program. Mr. Scavilla, currently CEO of Globus Medical, is a seasoned executive with a deep skillset in commercial deployment and business integration, having successfully led the merger of Globus and NuVasive. Mr. B
Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference Call on February 27th
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 27, 2025, at 8:30 am ET to review its fourth quarter and full year 2024 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register
Dentsply Sirona Announces Repositioning of Byte within Aligner Portfolio
CHARLOTTE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company plans to refocus the Byte business model around treatments that include expanded in-person dentist oversight. The Company is evaluating the go-to-market business and economic model and expects to leverage collaborative direct-to-consumer ("DTC") demand generation with dentists using Byte core competencies, expand digital customer journey management across the aligner portfolio, and utilize Byte skillsets to further enhance customer service and marketing across the Company. In connection with this review, Dentsply Sirona is not reinstati
Dentsply Sirona to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CHARLOTTE, N.C., Jan. 08, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will participate in the 43rd Annual J.P. Morgan Healthcare Conference. Management is scheduled to present on Wednesday, January 15, 2025, at 7:30 am PT (10:30 am ET). Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of innovation a
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., Dec. 13, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on January 10, 2025, to holders of record as of December 27, 2024. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental
Dentsply Sirona to Participate in the 7th Annual Evercore ISI HealthCONx Conference
CHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will participate in the 7th Annual Evercore ISI HealthCONx Conference. Management is scheduled to participate in a fireside chat discussion on December 5, 2024, at 8:20 am ET. Investors and other interested parties will be able to access a live audio webcast and audio webcast replay by visiting the Investors section of the Dentsply Sirona website at https://investor.dentsplysirona.com. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of inn
DENTSPLY SIRONA Inc. Analyst Ratings
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Dentsply Sirona downgraded by Needham
Needham downgraded Dentsply Sirona from Buy to Hold
Wells Fargo initiated coverage on Dentsply Sirona with a new price target
Wells Fargo initiated coverage of Dentsply Sirona with a rating of Equal Weight and set a new price target of $20.00
Dentsply Sirona downgraded by Jefferies with a new price target
Jefferies downgraded Dentsply Sirona from Buy to Hold and set a new price target of $20.00 from $30.00 previously
Dentsply Sirona downgraded by Evercore ISI with a new price target
Evercore ISI downgraded Dentsply Sirona from Outperform to In-line and set a new price target of $20.00
Mizuho initiated coverage on Dentsply Sirona with a new price target
Mizuho initiated coverage of Dentsply Sirona with a rating of Neutral and set a new price target of $21.00
Dentsply Sirona downgraded by Leerink Partners
Leerink Partners downgraded Dentsply Sirona from Outperform to Market Perform
Needham reiterated coverage on Dentsply Sirona with a new price target
Needham reiterated coverage of Dentsply Sirona with a rating of Buy and set a new price target of $29.00 from $34.00 previously
Needham reiterated coverage on Dentsply Sirona with a new price target
Needham reiterated coverage of Dentsply Sirona with a rating of Buy and set a new price target of $34.00
Leerink Partners initiated coverage on Dentsply Sirona with a new price target
Leerink Partners initiated coverage of Dentsply Sirona with a rating of Outperform and set a new price target of $42.00
Needham initiated coverage on Dentsply Sirona with a new price target
Needham initiated coverage of Dentsply Sirona with a rating of Buy and set a new price target of $35.00
DENTSPLY SIRONA Inc. Insider Purchases
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Amendment: Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 8% to 66,730 units (SEC Form 4)
4/A - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 7% to 71,730 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
President, CEO & Member of BOD Campion Simon D bought $200,341 worth of shares (11,306 units at $17.72), increasing direct ownership by 4% to 272,247 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Director Lucier Gregory T bought $199,983 worth of shares (8,212 units at $24.35), increasing direct ownership by 14% to 66,661 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Lucier Gregory T bought $99,976 worth of shares (3,577 units at $27.95), increasing direct ownership by 7% to 58,374 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Lucier Gregory T bought $314,400 worth of shares (10,000 units at $31.44), increasing direct ownership by 30% to 43,121 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Coleman Glenn bought $297,000 worth of shares (10,000 units at $29.70), increasing direct ownership by 16% to 73,566 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Campion Simon D bought $297,000 worth of shares (10,000 units at $29.70), increasing direct ownership by 4% to 243,930 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
DENTSPLY SIRONA Inc. Insider Trading
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
SEC Form 4 filed by Director Mazelsky Jonathan Jay
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SEC Form 4 filed by EVP, Corp Dev, GC & Secretary Rosenzweig Richard C
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SEC Form 4 filed by VP, Chief Accounting Officer Czerney Kevin
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SEC Form 4 filed by President, CEO & Member of BOD Campion Simon D
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SVP, Chief Supply Chain Office Johnson Robert Anthony was granted 35,983 shares and covered exercise/tax liability with 2,403 shares, increasing direct ownership by 38% to 121,292 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
SVP, CHRO Frohning Andrea L. was granted 20,013 shares and covered exercise/tax liability with 792 shares, increasing direct ownership by 135% to 33,415 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
EVP, Corp Dev, GC & Secretary Rosenzweig Richard C was granted 33,771 shares and covered exercise/tax liability with 7,848 shares, increasing direct ownership by 46% to 82,823 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
VP, Chief Accounting Officer Czerney Kevin covered exercise/tax liability with 534 shares and was granted 8,717 shares, increasing direct ownership by 45% to 26,427 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
President, CEO & Member of BOD Campion Simon D covered exercise/tax liability with 8,627 shares, decreasing direct ownership by 3% to 266,721 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)
4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)
DENTSPLY SIRONA Inc. SEC Filings
SEC Form S-3ASR filed by DENTSPLY SIRONA Inc.
S-3ASR - DENTSPLY SIRONA Inc. (0000818479) (Filer)
DENTSPLY SIRONA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
SEC Form 10-K filed by DENTSPLY SIRONA Inc.
10-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
Amendment: SEC Form SCHEDULE 13G/A filed by DENTSPLY SIRONA Inc.
SCHEDULE 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
DENTSPLY SIRONA Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
DENTSPLY SIRONA Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
DENTSPLY SIRONA Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
DENTSPLY SIRONA Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)
SEC Form 10-Q filed by DENTSPLY SIRONA Inc.
10-Q - DENTSPLY SIRONA Inc. (0000818479) (Filer)
DENTSPLY SIRONA Inc. Leadership Updates
Live Leadership Updates
Dentsply Sirona Appoints David Ferguson as Global Business Unit Leader
CHARLOTTE, N.C., March 17, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (XRAY) today announced that David Ferguson has been appointed Senior Vice President, Global Business Unit Leader, effective March 14, 2025. In this role he will lead the global business unit teams managing the dental product portfolio, serve as a member of the Executive Management Team and report directly to Chief Executive Officer, Simon Campion. David Ferguson joins Dentsply Sirona with 25 years of experience in MedTech and healthcare with a proven track record of delivering results, competing in a global marketplace and leading global product strategy. Mr. Ferguson has se
Dentsply Sirona Appoints Michael Barber and Daniel Scavilla as New Board Members
CHARLOTTE, N.C., Feb. 06, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Michael J. Barber and Daniel T. Scavilla have been appointed to its Board of Directors (the "Board"), effective February 5, 2025. Mr. Barber brings over 40 years of experience in product management and innovation, including executive leadership roles at GE, where he was responsible for the transformation of the company's digital X-Ray program. Mr. Scavilla, currently CEO of Globus Medical, is a seasoned executive with a deep skillset in commercial deployment and business integration, having successfully led the merger of Globus and NuVasive. Mr. B
Dentsply Sirona Appoints Herman V. Cueto Interim Chief Financial Officer
CHARLOTTE, N.C., Dec. 03, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Herman V. Cueto, a seasoned healthcare executive, has been appointed Interim Chief Financial Officer, effective immediately. He brings over two decades of experience leading and working in finance organizations across the healthcare industry. Mr. Cueto will oversee the finance organization while Dentsply Sirona completes its ongoing search for the Company's next CFO. "We are fortunate to have Herman joining us as interim CFO during this important time in Dentsply Sirona's history," said Simon Campion, President and Chief Executive Officer. "Herman
Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors
Credo Technology Group Holding Ltd ("Credo" or the "Company") (NASDAQ:CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved power efficiency as data rates and corresponding bandwidth requirements increase throughout the data infrastructure market, today announced the appointment of Clyde Hosein to the Company's board of directors effective April 3, 2024. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240401894812/en/Credo Technology Group Holding Ltd Announces Appointment of Industry Veteran Clyde Hosein to Board of Directors (Photo: Business Wire) "Clyde's appointment to the Credo boar
GE Vernova and Solventum Set to Join S&P 500; Dentsply Sirona to Join S&P MidCap 400; Others to Join S&P SmallCap 600
NEW YORK, March 27, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: Solventum Corp. (NYSE:SOLV) will be added to the S&P 500 effective prior to the open of trading on Monday, April 1, replacing V.F. Corp. (NYSE:VFC), which will be moved to the S&P SmallCap 600 effective prior to the open of trading on Wednesday, April 3. V.F. will replace ModivCare Inc. (NASD: MODV) in the S&P SmallCap 600 also effective prior to the open of trading on April 3. S&P 500 and 100 constituent 3M Co. (NYSE:MMM) is spinning off Solventum in a transaction expected to be completed April 1. Following the spin-off, the parent 3M will rema
Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors
CHARLOTTE, N.C., Feb. 29, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Eric K. Brandt, who has served as a Director on the Company's Board of Directors (the "Board") for nearly twenty years and as Chairman of the Board for six years, has informed the Board of his intention to retire at the May 2024 annual meeting and that he will not be standing for re-election. Mr. Brandt commented, "As I think back on the past two decades and all of the challenges we've navigated together, I am grateful for the talented and dedicated individuals with whom I have had the privilege to serve. I am proud of the strong and diverse Boar
Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member
CHARLOTTE, N.C., Nov. 02, 2023 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Mr. Brian Gladden has been appointed to its Board of Directors (the "Board"), effective January 1, 2024, to fill the vacancy from Mr. Harry M. Jansen Kraemer, Jr.'s retirement on December 31, 2023. "On behalf of Dentsply Sirona and the Board of Directors, I am pleased to welcome Brian Gladden to the Board," said Eric K. Brandt, Non-Executive Chairman of the Board. "Brian brings more than 35 years of experience with a proven track record in setting strategic vision, building world-class organizations, and driving business growth and transformation.
Toothio Raises $4M Led By Craft Ventures to Revolutionize Dental Staffing
First-of-its-kind Solution Addresses Sweeping Shifts in Dental Labor Market, Empowering Professionals and Practices Across the US; Appoints Industry Veteran as Chief Commercial Officer PHOENIX, Aug. 16, 2023 /PRNewswire/ -- Toothio, the on-demand dental staffing platform connecting qualified professionals with practices, today announced a $4 million seed round led by Craft Ventures with participation from Burst Capital, Moving Capital, Revere Partners, and Rho Capital Partners. This investment follows an initial backing from AZ Crown, founders of Insight Enterprises (NASDAQ:NSIT). The capital infusion will be used to accelerate Toothio's growth by enhancing its technology, expanding into key
Dentsply Sirona Appoints Glenn Coleman as Chief Financial Officer
CHARLOTTE, N.C., Sept. 22, 2022 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Glenn Coleman has been appointed Executive Vice President and Chief Financial Officer, effective September 26, 2022. He succeeds Barbara Bodem, who has served as Interim Chief Financial Officer since May 2022. Ms. Bodem will remain with the company and continue to serve as an advisor to Mr. Coleman until October 24, 2022. Mr. Coleman brings 30 years of financial management expertise to Dentsply Sirona. He joins the Company from Integra Lifesciences Holdings Corporation ("Integra"), where he most recently served as Executive Vice President and Chi
Dentsply Sirona Appoints Simon Campion as Chief Executive Officer
CHARLOTTE, N.C., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Dentsply Sirona Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that Simon Campion has been appointed President and Chief Executive Officer and will join the Company's Board of Directors ("Board"), effective September 12, 2022. He succeeds John Groetelaars, who has served as Interim Chief Executive Officer since April 2022. Mr. Groetelaars will continue to serve on the Board. Mr. Campion joins Dentsply Sirona from Becton, Dickinson and Company ("BD"), where he most recently served as Executive Vice President and President of the Medical segment and prior to that served as President of the Interventional segment fol
DENTSPLY SIRONA Inc. Financials
Live finance-specific insights
Dentsply Sirona Reports Fourth Quarter and Full Year 2024 Results, Provides Full Year 2025 Outlook
FY24 net sales of $3,793 million decreased (4.3%), organic sales decreased (3.5%) including a (1.2%) Byte sales impactFY24 GAAP net loss of ($910) million or ($4.48) per share, adjusted EPS of $1.67Q4 net sales of $905 million decreased (10.6%), organic sales decreased (10.7%) including a (6.0%) Byte sales impactQ4 GAAP net loss of ($430) million or ($2.16) per share, adjusted EPS of $0.26FY25 outlook: net sales in the range of $3.50 billion to $3.60 billion with organic sales down (4.0%) to (2.0%); adjusted EPS of $1.80 to $2.00(1) CHARLOTTE, N.C., Feb. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial resul
Dentsply Sirona Initiates Review of Strategic Alternatives for Wellspect Healthcare
CHARLOTTE, N.C., Feb. 11, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company has initiated a process to evaluate strategic alternatives for its Wellspect Healthcare business ("Wellspect"). Wellspect is a leading provider of bladder and bowel management care products with an over 40-year history. Through its comprehensive portfolio of products and accessories from trusted brands like LoFric® and Navina™, Wellspect has delivered improved organic sales growth in recent years, including mid-to-high single digit growth for 2023 and through the first three quarters of 2024. The business is well-positioned in the larg
Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference Call on February 27th
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, February 27, 2025, at 8:30 am ET to review its fourth quarter and full year 2024 financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., Dec. 13, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on January 10, 2025, to holders of record as of December 27, 2024. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental
Dentsply Sirona Reports Third Quarter 2024 Results
Net sales of $951 million increased 0.5%, organic sales increased 1.3%GAAP gross margin of 52.1%, GAAP net loss of ($494) million or loss per share of ($2.46)Adjusted EBITDA margin of 17.9%, adjusted EPS of $0.50Revised FY24 outlook: expect organic sales of (3.5%) to (2.5%) (previously (1%) to flat); adjusted EPS of $1.82 to $1.86 (previously $1.96 to $2.02) CHARLOTTE, N.C., Nov. 07, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced its financial results for the third quarter of 2024. Third quarter net sales of $951 million increased 0.5% (organic sales increased 1.3%) compared to the third quarter
Dentsply Sirona to Host Conference Call Regarding Update on Byte Aligner Products
CHARLOTTE, N.C., Oct. 25, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced it will host a conference call to discuss its Byte Aligner business. Dentsply Sirona's management team will host an investor conference call and live webcast on October 25, 2024, at 9:00 am ET. For those planning to participate on the call, please register at https://register.vevent.com/register/BI91fb506c8c2944bca6e65629062dd357. A webcast replay of the conference call will be available on the Investors section of the Company's website following the call. About Dentsply Sirona Dentsply Sirona is the world's largest manufacturer of professional
Dentsply Sirona Provides Update on Byte Aligner Products
Voluntarily Suspends Sales and Marketing of Byte Aligners and Impression Kits Provides Select Preliminary Third Quarter 2024 Results CHARLOTTE, N.C., Oct. 24, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), today announced the voluntary suspension of sales and marketing of its Byte Aligners and Impression Kits while the Company conducts a review of certain regulatory requirements related to these products. The Company's decision was made in consultation with the U.S. Food and Drug Administration (FDA). In connection with this review, and Dentsply Sirona's proactive efforts to continuously improve its processes, the Comp
Dentsply Sirona to Host Third Quarter Conference Call on November 7th
CHARLOTTE, N.C., Oct. 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Thursday, November 7, 2024, at 8:30 am ET to review its third quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://register.
Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation
Net sales of $984 million decreased (4.2%), organic sales decreased (2.3%)GAAP gross margin of 51.9%, GAAP net loss of ($4) million or loss per share of ($0.02)Adjusted EBITDA margin of 17.5%, adjusted EPS of $0.49Revised FY24 outlook: organic sales down (1%) to flat (previously flat to up 1.5%); adjusted EPS of $1.96 to $2.02 (previously $2.00 to $2.10)Company repurchased $150 million of its common stock in Q2 2024; expects to repurchase $100 million of its common stock in Q3 2024Second phase of transformation includes an expected reduction in annualized operating expenses of $80 to $100 million over approximately 12 to 18 months CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- D
Dentsply Sirona to Host Second Quarter Conference Call on July 31st
CHARLOTTE, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced that the Company will be hosting an investor conference call and live webcast on Wednesday, July 31, 2024, at 8:30 am ET to review its second quarter financial results. A presentation related to the call will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. Conference Call / Webcast Information A live webcast will be available on the Investors section of the Company's website at https://investor.dentsplysirona.com. For those planning to participate on the call, please register at https://re
DENTSPLY SIRONA Inc. Large Ownership Changes
This live feed shows all institutional transactions in real time.
Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SEC Form SC 13G filed by DENTSPLY SIRONA Inc.
SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SEC Form SC 13G filed by DENTSPLY SIRONA Inc.
SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)
Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SEC Form SC 13G filed by DENTSPLY SIRONA Inc.
SC 13G - DENTSPLY SIRONA Inc. (0000818479) (Subject)
Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc. (Amendment)
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc. (Amendment)
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)
SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc. (Amendment)
SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)